Silvant Capital Management LLC Lowers Stock Position in Mettler-Toledo International Inc. (NYSE:MTD)

Silvant Capital Management LLC lessened its holdings in Mettler-Toledo International Inc. (NYSE:MTD - Free Report) by 44.1% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,342 shares of the medical instruments supplier's stock after selling 1,851 shares during the period. Silvant Capital Management LLC's holdings in Mettler-Toledo International were worth $2,841,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. CIBC Private Wealth Group LLC raised its holdings in shares of Mettler-Toledo International by 1.9% in the 3rd quarter. CIBC Private Wealth Group LLC now owns 435 shares of the medical instruments supplier's stock worth $472,000 after purchasing an additional 8 shares during the period. Maverick Capital Ltd. raised its holdings in shares of Mettler-Toledo International by 3.9% in the 4th quarter. Maverick Capital Ltd. now owns 241 shares of the medical instruments supplier's stock worth $348,000 after purchasing an additional 9 shares during the period. Personal CFO Solutions LLC raised its holdings in shares of Mettler-Toledo International by 2.2% in the 3rd quarter. Personal CFO Solutions LLC now owns 472 shares of the medical instruments supplier's stock worth $523,000 after purchasing an additional 10 shares during the period. Ancora Advisors LLC raised its holdings in shares of Mettler-Toledo International by 100.0% in the 1st quarter. Ancora Advisors LLC now owns 20 shares of the medical instruments supplier's stock worth $31,000 after purchasing an additional 10 shares during the period. Finally, Penserra Capital Management LLC raised its holdings in Mettler-Toledo International by 9.3% during the 4th quarter. Penserra Capital Management LLC now owns 118 shares of the medical instruments supplier's stock valued at $169,000 after acquiring an additional 10 shares during the period. Hedge funds and other institutional investors own 95.07% of the company's stock.

Mettler-Toledo International Trading Up 1.3 %

Shares of MTD traded up $16.29 during mid-day trading on Friday, reaching $1,300.84. 90,855 shares of the stock traded hands, compared to its average volume of 125,151. The firm has a fifty day moving average price of $1,260.35 and a 200 day moving average price of $1,161.06. The company has a market cap of $27.82 billion, a price-to-earnings ratio of 36.25, a price-to-earnings-growth ratio of 3.55 and a beta of 1.15. Mettler-Toledo International Inc. has a 1 year low of $928.49 and a 1 year high of $1,615.97.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its quarterly earnings results on Friday, February 9th. The medical instruments supplier reported $9.40 EPS for the quarter, missing analysts' consensus estimates of $10.32 by ($0.92). Mettler-Toledo International had a net margin of 20.82% and a negative return on equity of 904.59%. The firm had revenue of $934.90 million for the quarter, compared to analysts' expectations of $959.45 million. During the same quarter last year, the firm earned $12.10 earnings per share. The firm's revenue for the quarter was down 11.6% on a year-over-year basis. On average, sell-side analysts anticipate that Mettler-Toledo International Inc. will post 39.9 EPS for the current year.

Insider Buying and Selling

In related news, Director Elisha W. Finney sold 251 shares of the company's stock in a transaction on Monday, February 12th. The shares were sold at an average price of $1,177.35, for a total value of $295,514.85. Following the completion of the transaction, the director now directly owns 316 shares in the company, valued at $372,042.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, Director Elisha W. Finney sold 251 shares of the company's stock in a transaction on Monday, February 12th. The shares were sold at an average price of $1,177.35, for a total value of $295,514.85. Following the completion of the transaction, the director now directly owns 316 shares in the company, valued at $372,042.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Shawn Vadala sold 300 shares of the company's stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $1,210.83, for a total transaction of $363,249.00. Following the completion of the transaction, the chief financial officer now owns 4,914 shares of the company's stock, valued at $5,950,018.62. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 951 shares of company stock worth $1,170,256. Corporate insiders own 1.94% of the company's stock.

Analyst Ratings Changes

MTD has been the topic of a number of analyst reports. Evercore ISI boosted their target price on shares of Mettler-Toledo International from $1,200.00 to $1,300.00 and gave the company an "in-line" rating in a report on Thursday. Citigroup reissued a "sell" rating and set a $975.00 target price (down previously from $1,050.00) on shares of Mettler-Toledo International in a report on Monday, December 11th. Finally, StockNews.com raised shares of Mettler-Toledo International from a "hold" rating to a "buy" rating in a report on Sunday, March 31st. One investment analyst has rated the stock with a sell rating, three have given a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $1,233.25.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.